Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Kyeong | - |
dc.contributor.author | Goo, Ja-Il | - |
dc.contributor.author | Jung, Hwa Young | - |
dc.contributor.author | Kim, Minkyoung | - |
dc.contributor.author | Boovanahalli, Shanthaveerappa K. | - |
dc.contributor.author | Park, Hye Ran | - |
dc.contributor.author | Kim, Mun-Ock | - |
dc.contributor.author | Kim, Dong-Hyun | - |
dc.contributor.author | Lee, Hyun Sun | - |
dc.contributor.author | Choi, Yongseok | - |
dc.date.accessioned | 2021-09-06T11:57:31Z | - |
dc.date.available | 2021-09-06T11:57:31Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2012-12-15 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/106656 | - |
dc.description.abstract | A novel series of benzimidazole derivatives was prepared and evaluated for their diacylglycerol acyltransferase (DGAT) inhibitory activity using microsome from rat liver. Among the newly synthesized compounds, furfurylamine containing benzimidazole carboxamide 10j showed the most potent DGAT inhibitory effect (IC50 = 4.4 mu M) and inhibited triglyceride formation in HepG2 cells. Furthermore, compound 10j reduced body weight gain of Institute of Cancer Research mice on a high-fat diet and decreased levels of total triglyceride, total cholesterol, and LDL-cholesterol in the blood accompanied with a significant increase in HDL-cholesterol level. (C) 2012 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | OBESITY | - |
dc.subject | POTENT | - |
dc.title | Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Yongseok | - |
dc.identifier.doi | 10.1016/j.bmcl.2012.10.046 | - |
dc.identifier.scopusid | 2-s2.0-84870252419 | - |
dc.identifier.wosid | 000311425500035 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.22, no.24, pp.7456 - 7460 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 22 | - |
dc.citation.number | 24 | - |
dc.citation.startPage | 7456 | - |
dc.citation.endPage | 7460 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | OBESITY | - |
dc.subject.keywordPlus | POTENT | - |
dc.subject.keywordAuthor | Obesity | - |
dc.subject.keywordAuthor | Type II diabetes | - |
dc.subject.keywordAuthor | Triglycerides | - |
dc.subject.keywordAuthor | DGAT | - |
dc.subject.keywordAuthor | DGAT inhibitors | - |
dc.subject.keywordAuthor | Benzimidazole | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.